David Perrin
17Patents
4h-index
26Co-inventors
60Inventor score
Filing activity: May 25, 1984 → Jun 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4849335A | Method for detecting the mutagenicity of substances susceptible of inducing the deterioration of cellular DNA, utilizing the production of an SOS response | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8574546B2 | Substituted aryl-fluoroborates as imaging agents | Chemistry; Metallurgy | 7 | Active |
| US8114381B2 | Radiolabeled compounds and compositions, their precursors and methods for their production | Chemistry; Metallurgy | 5 | Active |
| US5492811A | Bacterial diagnostic probe | Physics | 5 | Expired |
| US10150804B2 | Compositions and methods for imaging cancer | Human Necessities | 4 | Active |
| US10882871B2 | 18/19F-labelled compounds which target the prostate specific membrane antigen | Chemistry; Metallurgy | 2 | Active |
| US6017711A | Bacterial diagnostic probe | Physics | 2 | Expired |
| US11396535B2 | Cyclic peptide analogs of melanocortin and amanitin and methods of making such | Chemistry; Metallurgy | 2 | Active |
| US10556023B2 | Substituted organofluoroborates as imaging agents | Chemistry; Metallurgy | 2 | Active |
| US11207432B2 | Substituted organofluoroborates as imaging agents | Chemistry; Metallurgy | 1 | Active |
| US5863721A | Bacterial diagnostic probe | Physics | 1 | Expired |
| US11884714B2 | Cyclic peptide analogs of melanocortin and amanitin and methods of making such | Chemistry; Metallurgy | 1 | Active |
| US11229632B2 | Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof | Human Necessities | 0 | Active |
| US12059416B2 | Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof | Human Necessities | 0 | Active |
| US12427209B2 | Dual mode 18F-labelled theranostic compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11504441B2 | Radiolabeled compounds targeting the prostate-specific membrane antigen | Chemistry; Metallurgy | 0 | Active |
| US10952987B2 | Combination of adrenalin with an antidepressant for use in the treatment of shocks | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.